Motivating Patients and Maintaining Rigor in Cardiovascular Clinical Trials

Cardiovascular research can feel like a “numbers game” from design and recruitment to analysis. Worldwide brings the experience, decisiveness and tailored solutions your program needs.

Dedicated cardiovascular teams, 30 years and counting

Worldwide wins the numbers game. We have more than three decades of experience in cardiovascular research, a presence in more than 60 countries, and extensive global trial experience in all phases of research—even involving more than 26,000 patients in a single trial. Yet every single program receives the attention and care of a dedicated team, enabling us to act quickly and effectively in close collaboration with key industry partners. 



Karen Hill, President of CVM & Evidence Business Units, has been with Worldwide Clinical Trials for more than 25 years, providing management and supervision to project managers and CRAs. Karen supervises global teams working on large cardiovascular outcome studies, as well as projects in other cardiovascular indications across all clinical trial phases.

Cultivating cardiovascular success stories one patient—and study—at a time 

Cardiovascular trials often require teamwide dedication to a broad scope and a patient, detail-oriented operational approach. At Worldwide, we believe each study relies on the commitment of the individuals involved. Find out how this comes through in everything we do.

Cardiovascular Experience

  • Acute Coronary Syndrome (ACS)
  • Angina
  • Anticoagulation
  • Atherosclerosis
  • Atrial Fibrillation
  • Cardiac Arrhythmias
  • Coronary Artery Disease (CAD)
  • Heart Failure
  • Hypertension
  • Ischemic Heart Disease
  • Myocardial Infarction
  • Pulmonary Arterial Hypertension (PAH)
  • Restenosis
  • Stroke/Cerebrovascular Disease – Prevention
  • Thrombosis

Our Dedicated Team